Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Riess

Showing results (41-50 of 313) with videos related to

Pageof 32
Sort By:
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 19, 2005
Relapsing pancreatitis due to a novel compound heterozygosity in the CFTR gene involving the second most common mutation in central and eastern Europe [CFTRdele2,3(21 kb)]Georg Lamprecht, Ulrike A Mau, Christian Kortum, et al.
Rare Diseases (Austin, Tex.)|May 4, 2016
The calpain-suppressing effects of olesoxime in Huntington's diseaseJonasz J Weber, Midea M Ortiz Rios, Olaf Riess, et al.
Neuropharmacology|June 8, 2017
Altered reactivity of central amygdala to GABA<sub>A</sub>R antagonist in the BACHD rat model of Huntington diseaseCharlotte Lamirault, Libo Yu-Taeger, Valérie Doyère, et al.
Molecular Neurodegeneration|January 8, 2011
Localization of sequence variations in PGC-1α influence their modifying effect in Huntington diseaseHong Van B Che, Silke Metzger, Esteban Portal, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 11, 2014
Screening of mutations in GNAL in sporadic dystonia patientsClaudia Dufke, Marc Sturm, Christopher Schroeder, et al.
NPJ Parkinson'S Disease|June 19, 2026
Altered light-dark phase-dependent behavioral responses and suprachiasmatic nucleus pathology in an α-synuclein rat model of Parkinson's diseaseHanna Weber, Meike Statz, Nicolas Casadei, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 4, 2006
CAG repeats in Restless Legs syndromeMarkus Konieczny, Peter Bauer, Jürgen Tomiuk, et al.
American Journal of Medical Genetics. Part A|March 23, 2013
Xq22.3-q23 deletion including ACSL4 in a patient with intellectual disabilityAnastasia Gazou, Angelika Riess, Ute Grasshoff, et al.
Brain Research. Molecular Brain Research|December 14, 2002
14-3-3 protein is a component of Lewy bodies in Parkinson's disease-mutation analysis and association studies of 14-3-3 etaAndreas Ubl, Daniela Berg, Carsten Holzmann, et al.
American Journal of Medical Genetics. Part A|April 25, 2013
12q24.33 deletion: report of a patient with intellectual disability and review of the literatureMartin Kehrer, Sylke Singer, Ute Grasshoff, et al.
Pageof 32

Showing results (41-50 of 313) with videos related to

Sort By:
Pageof 32
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 19, 2005
Relapsing pancreatitis due to a novel compound heterozygosity in the CFTR gene involving the second most common mutation in central and eastern Europe [CFTRdele2,3(21 kb)]Georg Lamprecht, Ulrike A Mau, Christian Kortum, et al.
Rare Diseases (Austin, Tex.)|May 4, 2016
The calpain-suppressing effects of olesoxime in Huntington's diseaseJonasz J Weber, Midea M Ortiz Rios, Olaf Riess, et al.
Neuropharmacology|June 8, 2017
Altered reactivity of central amygdala to GABA<sub>A</sub>R antagonist in the BACHD rat model of Huntington diseaseCharlotte Lamirault, Libo Yu-Taeger, Valérie Doyère, et al.
Molecular Neurodegeneration|January 8, 2011
Localization of sequence variations in PGC-1α influence their modifying effect in Huntington diseaseHong Van B Che, Silke Metzger, Esteban Portal, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 11, 2014
Screening of mutations in GNAL in sporadic dystonia patientsClaudia Dufke, Marc Sturm, Christopher Schroeder, et al.
NPJ Parkinson'S Disease|June 19, 2026
Altered light-dark phase-dependent behavioral responses and suprachiasmatic nucleus pathology in an α-synuclein rat model of Parkinson's diseaseHanna Weber, Meike Statz, Nicolas Casadei, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 4, 2006
CAG repeats in Restless Legs syndromeMarkus Konieczny, Peter Bauer, Jürgen Tomiuk, et al.
American Journal of Medical Genetics. Part A|March 23, 2013
Xq22.3-q23 deletion including ACSL4 in a patient with intellectual disabilityAnastasia Gazou, Angelika Riess, Ute Grasshoff, et al.
Brain Research. Molecular Brain Research|December 14, 2002
14-3-3 protein is a component of Lewy bodies in Parkinson's disease-mutation analysis and association studies of 14-3-3 etaAndreas Ubl, Daniela Berg, Carsten Holzmann, et al.
American Journal of Medical Genetics. Part A|April 25, 2013
12q24.33 deletion: report of a patient with intellectual disability and review of the literatureMartin Kehrer, Sylke Singer, Ute Grasshoff, et al.
Pageof 32